Placer Biosciences Inc.

Category: Pharmaceutical Manufacturing

Description: Placer Biosciences is a preclinical pharmaceutical company focused on the development of new medicines for the treatment and prevention of Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS). Our pipeline includes novel peripherally-restricted dual-receptor cannabinoid agonists that exploit the anti-inflammatory and anti-nociceptive properties of the endocannabinoid system in the gut. All while simultaneously avoiding the psychoactivity and adverse events associated with other cannabinoid products that reach the CNS. These new molecules may provide new treatment options for patients suffering from these debilitating diseases, especially pediatric populations, for which the FDA granted Orphan Drug Designation to our lead candidate for the treatment of Pediatric Ulcerative Colitis.

Website: https://www.placerbio.com/

City: Rocklin, California

Founded: 2024